Absence of blood and lymphatic vessels in the developing human cornea
- PMID: 17077668
- DOI: 10.1097/01.ico.0000214230.21238.3d
Absence of blood and lymphatic vessels in the developing human cornea
Abstract
Purpose: The normal human cornea is devoid of both blood and lymphatic vessels and actively maintains this avascularity (corneal angiogenic privilege). Whether and when corneal angiogenic privilege is achieved during development is unknown.
Methods: This study analyzed whether the cornea is primarily devoid of both blood and lymphatic vessels during intrauterine development or whether secondary regression of pre-existing vessels occurs before delivery. Indirect double immunohistochemistry was performed on 4-microm serial pupil-optic disc sections of paraffin-embedded human eyes stillborn at gestational ages of 17 to 41 weeks with antibodies against von Willebrand factor (vWF; factor VIII-associated antigen) as a panendothelial marker and with antibodies against lymphatic vessel endothelial hyaluronate receptor 1 (LYVE1) as a marker specific for lymphatic vascular endothelium.
Results: Human corneas were devoid of both vWF+++/LYVE-1(-) blood vessels and vWF+/LYVE-1+++ lymphatic vessels at all time-points analyzed. In contrast, there were numerous blood and lymphatic vessels detectable in the adjacent conjunctiva.
Conclusion: The normal human cornea is primarily avascular and devoid of both blood and lymphatic vessels. Corneal angiogenic privilege is already achieved very early during fetal intrauterine development. This suggests early and strong expression of both antiangiogenic and antilymphangiogenic factors in the human cornea during development.
Similar articles
-
Absence of lymphatic vessels in the developing human sclera.Exp Eye Res. 2014 Aug;125:203-9. doi: 10.1016/j.exer.2014.06.010. Epub 2014 Jun 27. Exp Eye Res. 2014. PMID: 24975208
-
Expression of the lymphatic marker podoplanin (D2-40) in human fetal eyes.Exp Eye Res. 2014 Oct;127:243-51. doi: 10.1016/j.exer.2014.07.026. Epub 2014 Aug 15. Exp Eye Res. 2014. PMID: 25135789
-
Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2127-35. Invest Ophthalmol Vis Sci. 2002. PMID: 12091407
-
Corneal lymphangiogenesis: implications in immunity.Semin Ophthalmol. 2009 May-Jun;24(3):135-8. doi: 10.1080/08820530902801320. Semin Ophthalmol. 2009. PMID: 19437348 Review.
-
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.Prog Retin Eye Res. 2013 May;34:89-124. doi: 10.1016/j.preteyeres.2013.01.001. Epub 2013 Jan 22. Prog Retin Eye Res. 2013. PMID: 23348581 Review.
Cited by
-
Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival.Cells. 2021 Jul 2;10(7):1661. doi: 10.3390/cells10071661. Cells. 2021. PMID: 34359831 Free PMC article. Review.
-
Lymphatics and lymphangiogenesis in the eye.J Ophthalmol. 2012;2012:783163. doi: 10.1155/2012/783163. Epub 2012 Mar 5. J Ophthalmol. 2012. PMID: 22523652 Free PMC article.
-
Lymphatic Vessel Network Structure and Physiology.Compr Physiol. 2018 Dec 13;9(1):207-299. doi: 10.1002/cphy.c180015. Compr Physiol. 2018. PMID: 30549020 Free PMC article. Review.
-
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo.Adv Sci (Weinh). 2024 Jul;11(25):e2401710. doi: 10.1002/advs.202401710. Epub 2024 Apr 6. Adv Sci (Weinh). 2024. PMID: 38582513 Free PMC article.
-
[Inhibition of angiogenesis in the anterior chamber of the eye].Ophthalmologe. 2007 Apr;104(4):336-44. doi: 10.1007/s00347-007-1512-2. Ophthalmologe. 2007. PMID: 17372736 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous